On Friday, VAALCO Energy, Inc. (NYSE:EGY)’s shares declined -7.41% to $2.00.
VAALCO Energy, Inc. (EGY) stated results for the first quarter of 2015.
First Quarter 2015 highlights:
Successfully drilled and accomplished two development wells on the new Etame platform, offshore Gabon. First production from the Etame 10-H and Etame 12-H wells occurred in February and April 2015, respectively.
Raised offshore Gabon production capacity 30% since the fourth quarter of 2014 with the two new wells which are presently producing a combined total of 4,600 gross barrels of crude oil per day (BOPD) (1,100 BOPD net to the Company).
Grew total production to 1,555,600 barrels of crude oil (Bbls) gross (380,000 Bbls net), up 6% contrast to 1,370,000 Bbls gross (360,000 Bbls net) in the first quarter of 2014.
VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas in the United States. The company owns producing properties and conducts exploration activities as an operator of consortiums internationally in Gabon and Angola, in addition to conducts exploration activities as a non-operator in Equatorial Guinea, West Africa.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)’s shares dropped -7.20% to $3.74.
Rigel Pharmaceuticals, Inc. (RIGL) stated financial results for the first quarter ended March 31, 2015.
For the first quarter of 2015, Rigel stated a net loss of $18.2 million, or $0.21 per share, contrast to a net loss of $22.3 million, or $0.25 per share, in the first quarter of 2014. Weighted average shares outstanding for the first quarters of 2015 and 2014 were 88.0 million and 87.5 million, respectively.
Contract revenues from collaborations of $2.2 million in the first quarter of 2015 were comprised of $2.1 million from the amortization of the $30.0 million upfront payment from Bristol-Myers Squibb (BMS) following the partnership and license agreement executed in February 2015 for the discovery, development and commercialization of potential immuno-oncology therapeutics and $106,000 for Rigel’s performance of research activities in connection with the partnership agreement with BMS. There were no contract revenues from collaborations during the three months ended March 31, 2014.
Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders.
At the end of Friday’s trade, Envestnet Inc (NYSE:ENV)‘s shares dipped -6.80% to $48.82.
Envestnet Inc (ENV) stated financial results for its first quarter ended March 31, 2015. Financial Results for the First Quarter of 2015 Contrast to the First Quarter of 2014:
- Adjusted Revenues(1)raised 23% to $96.5 million for the first quarter of 2015 from $78.5 million for the first quarter of 2014.
- Revenues from assets under administration (AUM) or assets under administration (AUA) raised 21% to $81.1 million for the first quarter of 2015 from $67.1 million for the first quarter of 2014; total revenues, which comprise licensing and professional services fees, raised 23% to $96.5 million for the first quarter of 2015 from $78.5 million for the first quarter of 2014.
- Adjusted EBITDA(1)raised 43% to $16.8 million for the first quarter of 2015 contrast to $11.8 million for the first quarter of 2014.
- Adjusted Net Income(1)was $8.2 million, or $0.22 per diluted share, for the first quarter of 2015 contrast to $6.3 million, or $0.17 per diluted share, for the first quarter of 2014.
Envestnet, Inc., together with its auxiliaries, provides wealth administration software and services to independent financial advisors and financial institutions in the United States and internationally. Its wealth administration software unifies the applications and services advisors use to manage their practice and advise their clients, counting financial planning; capital markets assumptions; asset allocation guidance; research and due diligence on investment managers and funds; portfolio administration, trading, and rebalancing; multi-custodial and aggregated performance reporting; and billing calculation and administration.
Windstream Holdings, Inc. (NASDAQ:WIN), ended its Friday’s trading session with -6.61% loss, and closed at $9.18.
Windstream Holdings, Inc. (WIN) board of directors declared a prorated $.15 per share quarterly dividend to Windstream shareholders.
Shareholders of record on June 30, 2015, will receive a cash dividend of $.1104 per share, which represents a prorated dividend for the period April 25, 2015 through June 30, 2015. The dividend is payable on July 15, 2015.
Windstream Holdings, Inc. provides communications and technology solutions in the United States. It offers managed services and cloud computing services to businesses, in addition to broadband, voice, and video services to consumers primarily in rural markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
